The Global Market for Kidney Stone Management Devices is Projected to Reach US$1.6 Billion by 2024
Growing Volume of Kidney Stone Removal Procedures &
Technology Advancements to Drive the Global Kidney Stone Management Devices
Market, According to a New Report by Global Industry Analysts, Inc.
GIA launches comprehensive
analysis of industry segments, trends, growth drivers, market share, size and
demand forecasts on the global Kidney Stone Management Devices market. The global market for Kidney Stone Management Devices
is projected to reach US$1.6 billion by 2024, driven by rise in incidence of Urolithiasis, high kidney stone
recurrence rate, product developments, and improving access to treatment.
Kidney Stone formation,
also known as Urolithiasis is amongst the most common urological disorders
worldwide, affecting two in every thousand people annually worldwide. Growth in
the kidney stone management devices market is primarily driven by rise in
incidence of Urolithiasis or kidney stone disease led by the surge in systemic
disorders such as diabetes mellitus, and hypertension. Hence, an expanding geriatric population, and increasing obese
population play a major role in driving the urinary stone management devices
market. Further, increasing investments on the technology front and growing
number of strategic collaborations by the players are expected to spur growth
in the kidney stone management devices market.
Extracorporeal Shock Wave Lithotripsy represents the largest treatment type for Kidney
Stone Management Devices market while Intracorporeal Lithotripsy constitutes
the fastest growing segment. Growth in
the Intracorporeal Lithotripsy market is primarily driven by factors such as
reduced cost, and early recovery in comparison to shock treatments. Tubeless
Percutaneous nephrolithotomy (PCNL) is emerging as treatment of choice for
management of renal and upper ureteral stones in select patients. The procedure
is associated with shorter hospital stay, shorter operative time, and shorter
recuperation period.
Technology advancements in
the area of lithotripsy and ureteroscopy
continue to redefine the kidney stone management landscape. The introduction of
flexible ureteroscopes represents a major advancement in the urolithiasis
treatment market given its efficacy in the treatment of intrarenal and proximal
kidney stones. Growth in the modality is also supported by the improvement in
image quality following the introduction of high definition cameras and digital
imaging that facilitate improved visualization and more precise treatment. The market continues to witness a notable
growth in the holmium lasers for the management of kidney stones. Companies are
also focusing on development of mobile and compact affordable lithotripters to
widen reach to small hospitals and remote settings.
As stated by the new
market research report on Kidney Stone Management Devices, the U.S. represents the largest markets worldwide.
Asia-Pacific is the fastest growing market with a CAGR of 6.6% over the
analysis period given the high incidence of kidney stone disease, rise in
medical tourism and resultant volume of kidney stone procedures, improved healthcare
spending, and increased access to advanced treatment modalities.
Major players in the
market include Becton Dickinson and Company, Boston Scientific Corporation, Coloplast
Group, Cook Medical, DirexGroup, Dornier MedTech, EDAP TMS SA, E.M.S. Electro
Medical Systems S.A., Lumenis Ltd., New Star Lasers Inc., Olympus Corporation,
Richard Wolf GmbH, Siemens Healthineers, and Storz Medical AG, among others.
The research report titled
“Kidney Stone Management Devices: A Global Strategic
Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market estimates and
projections for all major geographic markets, such as the US, Canada, Japan,
Europe (France, Germany, Italy, UK, Spain, Russia, Rest of Europe),
Asia-Pacific (China, India, and Rest of Asia-Pacific), The Middle East &
Africa, Latin America (Brazil, and Rest of Latin America). The global market is analyzed by the following
treatment types: Extracorporeal Shock Wave Lithotripsy, Percutaneous
Nephrolithotomy, and Intracorporeal Lithotripsy.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To
connect with us, visit our LinkedIn page.
Comments
Post a Comment